|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02661 QINGSONG HEALTH
Nominal 
() | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 945,006 | 92.874% | 489,961 | 393,607 |
| Cost of Sales | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (50,302) | 11.564% | (45,088) | (145,834) | |
| Profit / (Loss) on Disposal | 282 | -- | (51) | -- | |
| Other Non-operating Items | (12,085) | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | |
| Profit / (Loss) before Taxation | 7,380 | -92.940% | 104,535 | 6,339 | |
| Taxation | 1,610 | -- | (7,366) | (15,437) | |
| Profit / (Loss) from Discontinued Operations | 1,408 | -- | (23,553) | 7,004 | |
| Non-controlling Interests | 0 | -- | 29 | 33 | |
| Others | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 10,398 | -85.881% | 73,645 | (2,061) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (8,914) | 40.091% | (6,363) | 1,904 |
| Depreciation & Amortisation | 4,975 | 6.577% | 4,668 | 5,767 |
| Directors' Emoluments | 6,368 | 3.933% | 6,127 | 6,971 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | |
| EPS (cts) | -- | -- | -- | -- |
| DPS (cts) | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- |
| NBV per share ($) | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 18/12/2025 13:50 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 86,045 |
| %Change | 437.916% |
| EPS / (LPS) | RMB -- |
| NBV Per Share (¥) | RMB -- |